Page 2 - Solution Group Bhd News Today

KUALA LUMPUR: Solution Group Bhd (SGB) has announced that the CanSino Biologics Inc’s single-dose Convidecia vaccine has obtained conditional approval as a booster shot from Malaysia’s Drug Control Authority (DCA), under the National Pharmaceutical Regulatory Agency (NPRA).

Study shows jab is effective as booster against spread of Covid variants, Solution Biologics says.

Based on corporate announcements and news flow on Friday, companies that may be in focus next Monday (Jan 10) include Minetech Resources Bhd, Mah Sing Group Bhd, SMTrack Bhd, Solution Group Bhd, Grand Hoover Bhd, MSM Malaysia Holdings Bhd, UMW Holdings Bhd, VS Industry Bhd, MMC Corp Bhd and Sarawak Cable Bhd.

SEPANG, Aug 20 ― Malaysia today received the first batch of the China-made single-dose CanSino Covid-19 vaccine to boost the momentum of the National Covid-19 Immunisation Programme (PICK), especially in rural areas. A total of 200,000 doses of CanSino vaccine developed by CanSino Biologics Inc...

Malaysia today received the first batch of the China-made single-dose CanSino vaccine to boost the momentum of the National Covid-19 Immunisation Programme (PICK), especially in rural areas

Solution Group to supply CanSino vaccine in Malaysia A - Solution Group Bhd’s (SGB) wholly-owned subsidiary Solution Biologics Sdn Bhd (Solbio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine for use against Covid-19. In a statement, the group said the finished product agreement allows Solbio to purchase and CanSino to supply the finish product vaccine for emergency use in Malaysia...

Copy URL The finished product agreement allows Solution Biologics to purchase and CanSino to supply the finished vaccine for emergency use in Malaysia. – AFP pic, July 30, 2021. SOLUTION Group Bhd’s (SGB) wholly owned subsidiary, Solution Biologics Sdn Bhd (Solbio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine against Covid-19. In a statement, the group said the finished product agreement all...

FILE PHOTO: Vials of a COVID-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc and a team led by Chinese military infectious disease expert, are pictured in Wuhan, Hubei province, China March 24, 2020. China Daily via REUTERS KUALA LUMPUR (Bernama): Solution Group Bhd’s (SGB) wholly-owned subsidiary, Solution Biologics Sdn Bhd (SolBio) has signed a finished product and a bulk product agreement today w...

has entered into a supply agreement with the Health Ministry to supply Convidicea, a recombinant novel coronavirus vaccine also known as adenovirus type 5 vaccine. In a statement, Solution said its wholly-owned subsidiary Solution Biologics Sdn Bhd (SOLBIO) would supply 3.5 million doses of the vaccine to MOH. The vaccine was jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences. CanSino has also authorised SOLBIO and granted it...

Moderna Inc won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.